| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_464140da2bc9c91ef0f16dafeccf2500 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-4283
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-3061
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-532
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-42 |
| filingDate |
2005-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac16c27ec33174d9f7c073b61d69a5cf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ba19413227211239992cdd8fd1b6145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8bb6a4f1365dcb7a9c0bd43c17e6be57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_43c818a76b8c98a6d57d6cee1ba86243
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_102ba55a2d368c1aa6f286ff501a1ca6 |
| publicationDate |
2006-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1720569-A1 |
| titleOfInvention |
Target for b-cell disorders |
| abstract |
The present invention relates to the diagnosis and treatment of B-cell disorders such as multiple myeloma (MM). In particular, the present invention relates to the treatment of B-cell disorders using ligands which bind to free lambda light chains expressed on the surface of lymphoid cancer cells. |
| priorityDate |
2004-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |